Why Chlamydia pneumoniae is associated with asthma and other chronic conditions? Suggestions from a survey in unselected 9 yr old schoolchildren
Roberto Ronchetti
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorGian Luca Biscione
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorFrancesco Ronchetti
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorMaria Paola Ronchetti
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorSusy Martella
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorCarlo Falasca
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorCarolina Casini
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorMario Barreto
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorMaria Pia Villa
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorRoberto Ronchetti
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorGian Luca Biscione
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorFrancesco Ronchetti
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorMaria Paola Ronchetti
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorSusy Martella
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorCarlo Falasca
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorCarolina Casini
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorMario Barreto
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorMaria Pia Villa
Pediatric Clinic, Second School of Medicine, Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Search for more papers by this authorAbstract
Despite numerous studies demonstrating an association between asthma and many other chronic conditions and signs of Chlamydia pneumoniae (Cp) infection, the role of Cp in the pathogenesis of these illness remain still unclear. We investigated the prevalence of Cp antigen in the upper airways and the prevalence of detectable Cp serum antibodies in an unselected population of 207 9-yr-old schoolchildren. We also sought the presence of asthma, chronic or recurrent respiratory symptoms by means of questionnaire completed by the parents. Nasal aspirate, blood sampling and allergen skin prick tests were also performed. None of the children had obvious signs of acute infection at physical examination. Cp DNA was detected in nasal aspirates from 20 of the 207 children tested and serum IgG antibodies for Cp in 68 children. No association was found between atopy or history of atopic illness and the presence of Cp DNA or antibody production. This finding is explained by the fact that our study was conducted in an unselected childhood population, inherently including few children with asthma. A strong association between the status of antigen carrier and the presence of detectable Cp serum immunoglobulin (Ig)G or IgM suggests that subjects with detectable Cp antibodies have an impaired ability to eliminate this pathogen when infected. Because Cp eradication requires a strong Th1 lymphocyte response, the previously proven association between Cp and asthma, might reflect the known association of asthma with Th2-oriented lymphocytic activity.
References
- 1 Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995: 8: 451–61.
- 2 Hammerschlag MR, Chirgwin K, Roblin PM, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992: 14: 178–82.
- 3 Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae and chronic pharyngitis. Scand J Infect Dis 1995: 27: 179–82.
- 4 Hahn MS. Chlamydia pneumoniae, asthma, and COPD: it is the evidence? Ann Allerg 1999: 23: 271–91.
- 5 Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992: 116: 273–8.
- 6 Gaydos C.A. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis 2000: 181(Suppl. 3): S473–8.
- 7 Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association or prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992: 268: 68–72.
- 8 Rosenfeld ME, Blessing E, Lin TM, Moazec TC, Campbell LA, Kuo C. Chlamydia, inflammation, and atherogenesis. J Infect Dis 2000: 181(Suppl. 3): S492–7.
- 9 Ronchetti F, Ronchetti R, Guglielmi F, et al. Detection of Chlamydia pneumoniae in cholesteatoma tissue: any pathogenetic role? Otol Neurotol 2003: 24: 353–7.
- 10 Lundemose JB, Lundemose GA, Gregersen M, et al. Chlamydia and sudden infant death syndrome. A study of 166 SIDS and 30 control cases. Int J Legal Med 1990: 104: 3–7.
- 11 Falck G, Gnarpe J, Gnarpe H. Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections. Pediatr Infect Dis 1997: 16: 549–54.
- 12 Ferris BG. Epidemiology Standardization Project. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Resp Dis 1978: 118: 7–53.
- 13 Barreto M, Villa MP, Martella S, et al. Exhaled nitric oxide in asthmatic and no asthmatic children: influence of the type of allergen sensitization and exposure to tobacco smoke. Pediatr Allergy Immunol 2001: 12: 247–56.
- 14 Ronchetti R, Villa MP, Martella S, et al. Nasal cellularity in 183 unselected schoolchildren aged 9–11 years. Pediatrics 2002: 110: 1137–42.
- 15 Ronchetti R, Bonci E, Cutrera R, et al. Enhanced allergic sensitisation related to parental smoking. Arch Dis Child 1992: 67: 496–500.
- 16 Johnston SL, Sanderson G, Pattemore PK, et al. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol 1993: 31: 11–7.
- 17 Mills GD, Lindeman JA, Fawcett JP, et al. Chlamydia pneumoniae serological status is not associated with asthma in children or young adults. Int J Epidemiol 2000: 9: 280–4.
- 18 Lieberman D, Lieberman D, Printz S, et al. Atypical pathogen infection in adults with acute axacerbation of bronchial asthma. Am J Respir Crit Care Med 2003: 167: 406–10.
- 19 Foschino Barbaro MP, Resta O, Aliani M, et al. Seroprevalence of chronic Chlamydia pneumoniae infection in patients affected by chronic stable asthma. Clin Microbiol Infect 2002: 8: 358–62.
- 20 Schmidt SM, Muller CE, Bruns R, et al. Bronchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children. Pediatr Allergy Immunol 2001: 12: 257–65.
- 21 Hyman CL, Roblin PM, Graydos CA, Quinn TC, Schachter J, Hammerschlag MR. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 1995: 20: 1174–8.
- 22 Ferrari M, Poli A, Olivieri M, et al. Seroprevalence of Chlamydia pneumoniae antibodies in a young adult population sample living in Verona. European Community Respiratory Health Survey (ECRHS) Verona. Infection 2000: 28: 38–41.
- 23 Gnarpe J, Gnarpe H, Sundelöf B. Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons. Scand J Infect Dis 1991: 23: 387–8.
- 24 Falck J, Gnarpe J, Gnarpe H. Persistent Chlamydia pneumoniae infection in a Swedish family. Scand J Infect Dis 1997: 28: 271–3.
- 25 Normann E, Gnarpe J, Gnarpe H, Wettegren B. Chlamydia pneumoniae in children with acute respiratory tract infection. Acta Pediatr 1998: 87: 23–7.
- 26 Block SL, Hammerschlag MR, Hedrick J, et al. Chlamydia pneumoniae in acute otitis media. Pediatr Infect Dis J 1997: 16: 858–62.
- 27 Saikku P, Ruutu P, Leinonen M, Panelius J, Tupasi TE, Grayston JT. Acute lower respiratory tract infection associated with Chlamydial TWAR antibody in Filipino children. J Infect Dis 1988: 158: 1095–7.
- 28 Wang SP, Grayston JT. Population prevalence antibody to Chlamydia pneumoniae strain TWAR. In: WR Bowie, HD Caldwell, RP Jones, et al. eds. Chlamydial infections. Cambridge: Cambridge University Press, 1990: 402–5.
- 29 Blasi F, Cosentini R, Schoeller MC, Lupo A, Allegra L. Chlamydia Pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan. Thorax 1993: 48: 1261–3.
- 30 Karvonen M, Tuomilehto J, Pitkaniemi J, Saikku P. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972–1987. Epidemiol Infect 1993: 110: 349–60.
- 31 Aldous MB, Grayston JT, Wang SP, Foy H. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966–1970. J Infect Dis 1992: 166: 646–9.
- 32 Einarsson S, Sigurdsson HK, Magnusdottir SD, Erlensdottir H, Briem H, Gudmunsson S. Age specific prevalence of antibodies against Chlamydia pneumoniae in Ireland. Scand J Infect Dis 1994: 26: 393–7.
- 33 Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect Dis 1992: 25 (Suppl. 1): 27–34.
- 34 Cook PJ, Honeybourne D. Chlamydia pneumoniae. J Antimicrob Chemother 1994: 34: 859–73.
- 35 Holland MJ, Bailey RL, Conway DJ, et al. T helper type-1 (Th1/Th2 profiles of peripheral blood mononuclear cells (PMBC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996: 105: 429–35.
- 36 Von Hertzen LC. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur Respir J 2002: 19: 546–56.
- 37 Rottemberg ME, Gigliotti Rothfuchs A, Gigliotti D, et al. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analysed in genetically modified mice. J Immunol 1999: 162: 2829–36.